Oncolytics Biotech (ONCY)

2.64 -0.04  -1.49%  May 17, 8:00PM
Add to Watchlists Create an Alert

Oncolytics Biotech Cash from Financing TTM:

20.96M for Dec. 31, 2012
View Full Chart

Oncolytics Biotech Cash from Financing TTM Chart

    Oncolytics Biotech Historical Cash from Financing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 20.96M
    Sept. 30, 2012 21.38M
    June 30, 2012 19.50M
    March 31, 2012 19.76M
    Dec. 31, 2011 14.53M
    Sept. 30, 2011 41.54M
    June 30, 2011 42.26M
    March 31, 2011 42.40M
    Dec. 31, 2010 27.29M
    Sept. 30, 2010 27.23M
    June 30, 2010 27.96M
    March 31, 2010 35.11M
    Dec. 31, 2009 35.13M
    Sept. 30, 2009 10.82M
    June 30, 2009 10.08M
    March 31, 2009 2.874M
    Dec. 31, 2008 2.857M
       
    Sept. 30, 2008 0.2423M
    June 30, 2008 1.024M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro

    About Cash From Financing (TTM)

    Definition: Cash from Financing

    Learn More

    Get data for

    ONCY Cash from Financing TTM Benchmarks

    Companies
    Optimer Pharmaceuticals 6.882M
    Nektar Therapeutics 26.80M
    Bioline Rx 13.32M

    ONCY Cash from Financing TTM Rankings

    Overall 82nd percentile
    1298 of 7590
    Sector 74th percentile
    164 of 651 in Healthcare
    Industry 64th percentile
    84 of 238 in Biotechnology

    ONCY Cash from Financing TTM Range, Past 5 Years

    Minimum 0.2423M Sep 2008
    Maximum 42.40M Mar 2011
    Average 21.21M